A company has a capability relevant to an important health challenge, one that needs the combined effort of research, clinical and industrial partners across countries to address. Joining a consortium would let it apply its capability in that larger effort, alongside leading partners, and have its part funded, but it needs the right call and a credible role within a strong consortium.
Horizon Europe is the European Union's framework programme for research and innovation, and health is one of its thematic clusters. Much of it funds collaborative projects carried out by consortia of partners from several countries, companies, universities, research institutions and sometimes clinical or public-health partners working together on a shared objective. The grant covers a share of each partner's eligible costs: up to the full eligible cost for research and innovation actions, and a lower share for innovation actions closer to market. The figure shown is the company's funded share of the project. It suits a company that wants to bring its capability into an ambitious European health effort and have that contribution funded.
The company joins a consortium applying to a relevant Horizon Europe health call and takes responsibility for a defined part of the work. Its eligible costs, mostly the personnel on its contribution, with related costs, are funded at the applicable rate for the type of action. Its funded share comes to about EUR 0.9 million over the project. The other partners are funded for their own parts in parallel, and the consortium pursues an outcome beyond any single partner's reach.
Horizon Europe runs through calls under its clusters, including health, each with a scope and a deadline. A consortium of partners from several countries prepares one joint proposal covering the objective, the work packages, the partner roles and the expected impact, evaluated on excellence, impact and quality of implementation. Successful consortia sign a grant agreement under which each partner is funded for its own eligible costs at the applicable rate. In health, consortia often need to combine research, industrial and clinical or public-health partners, so assembling the right mix early, before the deadline, is a central part of a strong application.
A €0.9M Horizon Europe grant.
The company contributes its capability to an ambitious European health project, works with leading research and clinical partners, and has its contribution funded. It gains both the funding and a position in a network that often leads to follow-on work and to the credibility that matters in a regulated, evidence-driven field.
Horizon Europe (collaborative) · up to 100%Horizon Europe lets a company contribute to and be funded within a European health project it could not run alone. The programme funds the company's share, and the consortium brings research and clinical partners and reach beyond its own. The essentials are a fitting health call, a strong consortium and a clear, well-scoped role.
The questions we hear most. Short answer first, detail after.
Yes. Health is one of the thematic clusters of Horizon Europe, funding collaborative research and innovation by consortia of companies, universities and research institutions across countries.
Up to the full eligible cost for research and innovation actions, and a lower share for innovation actions closer to market. The figure shown is the company's funded share of the project.
Typically a mix of companies, universities, research institutions and sometimes clinical or public-health partners from several countries, with each responsible for a defined part of the work.
As part of a consortium, to a specific Horizon Europe health call with a deadline, submitting one joint proposal evaluated against the call's criteria.
How a manufacturing SME secured a BAFA EEW grant to replace compressed-air and motor systems with…
Read the storyHow a deep-tech company secured EIC Accelerator blended finance to scale a breakthrough hardware…
Read the storyHow a company secured an EU Innovation Fund grant for a grid-scale energy-storage demonstration -…
Read the storyHow a biotech SME secured Eurostars 3 funding for a transnational assay-development project - how…
Read the storyHow a university founder team secured the EXIST founder stipend to turn a research-based software…
Read the storyHow a medical-device manufacturer secured a GRW grant for a cleanroom capacity expansion in a…
Read the storyHow a deep-tech company secured its funded share of a multi-partner Horizon Europe consortium…
Read the storyHow a manufacturer financed a new product line with a low-interest KfW innovation loan - what a…
Read the storyTell us about your project. A funding advisor reviews your case by hand, then either comes back with feedback or a few follow-up questions. No obligation.
